EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cellular transcription factor TFII-I represses adenovirus gene expression

Rachel L White, Patrick Hearing iD

Journal of Virology · 2025

DOI: 10.1128/jvi.00618-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2025. Verfasst von Rachel L White und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA. Hauptthemen laut MEDLINE: Adenoviruses, Human, Gene Expression Regulation, Viral, Adenovirus E4 Proteins, Adenovirus Infections, Human. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To successfully replicate, viruses must overcome innate cellular antiviral responses. With human adenovirus (HAdV), a key viral repressor of cellular antiviral responses is the early protein E4ORF3. E4ORF3 relocalizes numerous cellular antiviral proteins, particularly those involved in the interferon (IFN) and DNA damage response (DDR) pathways, to sequester them from viral replication sites in the nucleus. E4ORF3 also directs SUMO modification of a subset of its targets, some of which are subsequently targeted for proteasomal degradation. We previously identified TFII-I, a cellular transcription factor and DNA repair protein, as one of the proteins most highly SUMOylated by E4ORF3, as well as one of the E4ORF3 degradation targets. In this study, we characterized the effect of TFII-I knockout (KO) on HAdV replication. TFII-I KO significantly increased the infectious virus yield from infected cells, supporting the hypothesis that TFII-I acts as a restriction factor during HAdV infection. TFII-I KO also significantly increased viral genome replication, as well as both early and late gene and protein expression. Our results do not support TFII-I acting as a part of either the DDR or IFN responses during HAdV infection. Our results characterize a novel antiviral function for TFII-I against HAdV that occurs during the early stage of the viral replication cycle and highlight the importance of studying viral countermeasures to the cellular antiviral response, like E4ORF3, to better understand how cells restrict viral infection. IMPORTANCE The cellular transcription factor TFII-I was previously shown to bind to HAdV late promoters and to E4-mutant viral genomes during replication. More recently, TFII-I was shown to be a degradation target of HAdV protein E4ORF3. Due to the long-established importance of E4ORF3 in countering cellular antiviral responses, this raised the question of whether TFII-I possesses an undiscovered antiviral role against HAdV. It was hypothesized that whether TFII-I played an antiviral role in HAdV infection, it was most likely to be as a repressor of the late transcriptional program. Here, we show the first direct evidence of TFII-I repressing HAdV infection and demonstrate that the inhibitory effect can be detected much earlier in the viral life cycle than previously predicted. Our findings provide insight into the role of TFII-I in the cellular antiviral response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenoviruses, HumanGene Expression Regulation, ViralAdenovirus E4 ProteinsAdenovirus Infections, HumanTranscription Factors, TFIIHumansVirus ReplicationHEK293 CellsHost-Pathogen InteractionsCell LineGenome, Viral

Stichwörter der Autor:innen

GTF2ITFII-IViral DNA Replicationadenovirusgene expression

Substanzen

Adenovirus E4 ProteinsTranscription Factors, TFII

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA.

ORCID-Profile: Patrick Hearing

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

White, R. L., & Hearing, P. (2025). Cellular transcription factor TFII-I represses adenovirus gene expression. Journal of Virology. https://doi.org/10.1128/jvi.00618-25

Vancouver

White RL, Hearing P. Cellular transcription factor TFII-I represses adenovirus gene expression. Journal of Virology. 2025. doi:10.1128/jvi.00618-25

BibTeX
@article{White2025,
  author = {White, Rachel L and Hearing, Patrick},
  title = {Cellular transcription factor TFII-I represses adenovirus gene expression},
  journal = {Journal of Virology},
  year = {2025},
  doi = {10.1128/jvi.00618-25}
}
Kostenlos starten →